Archives

by in
Entry Author Date Location
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
The Reimbursed Personal Genome—-Five Years Away? 02/19/13 New York
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News 10/01/10 Boston
Vertex CEO on Building a Blockbuster, Genzyme Investor on Fixing Up the Firm, Cubist CEO on Pipeline and Patent Challenges, & More Boston-Area Life Sciences News 01/28/10 Boston
Inside Seattle Genetics’ Big Partnership, Motricity Files for $250M IPO, VC Stats for 2009, & That’s About It for Seattle-Area Deals News 01/26/10 Seattle
Microsoft Buys Opalis and Sentillion, Swype and Widevine Raise Cash, Dendreon Rakes In $409M, & More Seattle-Area Deals News 12/15/09 Seattle
See You There Tomorrow at Pharma’s Bet on Boston Innovation 11/03/09 Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News 10/28/09 Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
A123Systems Gives Chrysler a Charge, Segway Scoots into GM Deal, Basho Banks $2M, & More Boston-Area Deals News 04/10/09 Boston
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News 04/09/09 Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News 04/07/09 Seattle
Hey Life Sciences Fans, Remember The Deals Back in 2008… 01/05/09 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
Millennium’s Velcade, As Time Wears On, Shows Durable Ability to Prolong Lives 12/08/08 Boston
Millennium CEO Dunsire Juggles Growing Pipeline, Works to Maintain Nimble Culture—as New Owner Takeda Makes the Company its Center for Cancer Drug Development 09/10/08 Boston
Takeda Takes Hold of Millennium for $8.8 Billion 04/10/08 Boston
Millennium Presents Positive Data for Velcade 12/11/07 Boston
Market Likes Millennium’s Velcade News; Analysts Not So Sure 09/18/07 Boston
Just Launched into the Boston VC Orbit: Third Rock Ventures 09/14/07 Boston
Page 1 of 1